Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: Implication for pathomechanisms of lesion formation

Journal of Neuroimmunology

Volumn 194, Issue 1-2, 2008, Pages 34-43

  Park, Il Kwon ^a   Hiraki, Keiko ^a   Kohyama, Kuniko ^a   Matsumoto, Yoh ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

7ND; Acute; Biphasic; Chronic EAE; Gene therapy; Macrophage

Indexed keywords

7ND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG INHIBITION; GENE THERAPY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE;

EID: 39849089290     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.11.012     Document Type: Article

References (32)

1. Agrawal H.C. Burton R.M. Fishman M.A. Mitchell R.F. Prensky A.L. Partial characterization of a new myelin protein component J. Neurochem. 19 1972 2083 2089
2. Bar-Or A. Oliveira E.M. Anderson D.E. Hafler D.A. Molecular pathogenesis of multiple sclerosis J. Neuroimmunol. 100 1999 252 259
3. Bas A. Forsberg G. Hammarstrom S. Hammarstrom M.L. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes Scand. J. Immunol. 59 2004 566 573
4. Casado V. Mallol J. Bozal J. Isolation and characterization of bovine brain myelin distribution of 5′-nucleotidase Neurochem. Res. 13 1988 349 357
5. Deibler G.E. Martenson R.E. Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species Prep. Biochem. 2 1972 139 165
6. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1 Hypertension 41 2003 834 841
7. Egashira K. Koyanagi M. Kitamoto S. Ni W. Kataoka C. Morishita R. Kaneda Y. Akiyama C. Nishida K.I. Sueishi K. Takeshita A. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis FASEB J. 14 2000 1974 1978
8. Gong J. Ratkay L.G. Waterfield J.D. Clark-Lewis I. An antagonisit of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL- lpr mouse model J Exp. Med. 186 1997 131 137
9. Goser S. Ottl R. Brodner A. Dengler T.J. Torzewski J. Egashira K. Rose N.R. Katus H.A. Kaya Z. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy Circulation 112 2005 3400 3407
10. Huang D.R. Wang J. Kivisakk P. Rollins B.J. Ransohoff R.M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis J. Exp. Med. 193 2001 713 726
11. Huitinga I. Van Roonijen N. De Groot C.J.A. Uitdehaag B.M.J. Dijkstra C.D. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages J. Exp. Med. 172 1990 1025 1033
12. Ikeda Y. Yonemitsu Y. Kataoka C. Kitamoto S. Yamaoka T. Nishida K. Takeshita A. Egashira K. Sueishi K. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats Am. J. Physiol. Heart Circ. Physiol. 283 2002 H2021 H2028
13. Jee Y. Yoon W.K. Okura Y. Tanuma N. Matsumoto Y. Upregulation of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats J. Neuroimmunol. 128 2002 49 57
14. Kennedy K.J. Steir R.M. Kunkel S.L. Lukacs N.W. Karpus W.J. Acute and relapsing experimental encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1 J. Neuroimmunol. 92 1998 98 108
15. Kim G. Tanuma N. Kojima T. Kohyama K. Suzuki Y. Kawazoe Y. Matsumoto Y. CDR3 size spectratyping and sequencing of spectratype-derived T cell receptor of spinal cord T cells in autoimmune encephalomyelitis J. Immunol. 160 1998 509 513
16. Lalive P.H. Menge T. Delarasse C. Della Gaspera B. Pham-Dinh D. Villoslada P. von Budingen H.C. Genain C.P. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis Proc. Natl. Acad. Sci. U S A 103 2006 2280 2285
17. Lassmann H. Recent neuropathological findings in MS-implication for diagnosis and therapy J. Neurol. Suppl. 4 2004 IV/2 IV/5
18. Lau E.K. Paavola C.D. Johnson Z. Gaudry J.P. Geretti E. Borlat F. Kungl A.J. Proudfoot A.E. Handel T.M. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo J. Biol. Chem. 279 2004 22294 22305
19. Lublin F.D. Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey Neurology 46 1996 907 911
20. Lucchinetti C. Brueck W. Parisi J. Scheithauer B. Rodoriguez M. Lassmann H. Heterogeity of multiple sclerosis lesions: implication for the pathogenesis of demyelination Ann. Neurol. 47 2000 707 717
21. Matsumoto Y. Fujiwara M. The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesion of EAE J. Neurol. Sci. 77 1987 35 47
22. Matsumoto Y. Tsukada Y. Miyakoshi A. Sakuma H. Kohyama K. C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy J. Immunol. 173 2004 3535 3541
23. Matsumoto Y. Sakuma H. Miyakoshi A. Tsukada Y. Kohyama K. Park I. Naoyuki T. Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor gene J. Neuroimmunol. 170 2005 49 61
24. Ohmori K. Hong Y. Fujiwara M. Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ Lab. Invest. 66 1992 54 62
25. Proudfoot A.E. Handel T.M. Johnson Z. Lau E.K. LiWang P. Clark-Lewis I. Borlat F. Wells T.N. Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc. Natl. Acad. Sci. U S A 100 2003 1885 1890
26. Sakuma H. Kohyama K. Park I.K. Miyakoshi A. Tanuma N. Matsumoto Y. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats Brain 127 2004 2201 2213
27. Sospendra M. Martin R. Immunology of multipel sclerosis Annu. Rev. Immunol. 23 2005 683 747
28. Tran E.H. Hoekstra K. Van Rooijen N. Dijkstra C.D. Owens T. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice J. Immunol. 161 1998 3767 3775
29. van der Goes A. Boorsma W. Hoekstra K. Montagne L. De Groot C.J.A. Dijkstra C.D. Determination of the sequential degradation of myelin protein by macrophages J. Neuroimmunol. 161 2005 12 20
30. von Budingen H.C. Hauser S.L. Fuhrmann A. Nabavi C.B. Lee J.I. Genain C.P. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination Proc. Natl. Acad. Sci. U S A 99 2002 8207 8212
31. Zhang Y. Rollins B.J. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer Mol. Cell Biol. 15 1995 4851 4855
32. Zhang Y.J. Rutledge B.J. Rollins B.J. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis J. Biol. Chem. 269 1994 15918 15924